Medical-device maker Boston Scientific has warned that a cybersecurity incident that disrupted its global operations is likely to prevent the company from meeting its previously issued third-quarter and full-year 2026 financial forecasts.
The incident, detected on August 25, affected parts of the company’s information-technology environment and caused significant network outages. The disruption affected manufacturing as well as the processing and shipment of customer orders, turning what began as a cybersecurity problem into a wider operational and financial issue.
Boston Scientific had previously forecast 2026 sales growth of 5.5% to 6.5% and adjusted earnings of $3.28 to $3.32 per share. It had also expected third-quarter sales growth of 3% to 5% and adjusted earnings of $0.80 to $0.82 per share. The company now says those targets are unlikely to be achieved because of the disruption.
Cyber Incident Disrupts Manufacturing
The impact of the attack extended well beyond corporate IT systems.
Boston Scientific said the incident disrupted manufacturing operations and its ability to process and ship customer orders. Those interruptions created a backlog that the company is now working to clear as systems and facilities return to normal.
Major distribution centers have resumed operations at or above normal levels, while manufacturing has recovered across most facilities. The company has also restored operations at its sterilization facilities.
The recovery means the immediate operational disruption is beginning to ease, but the financial consequences may continue as the company works through delayed orders and lost production.
Investors React to the Warning
The cybersecurity incident quickly became a financial-market story.
Boston Scientific shares fell after the company disclosed that it was unlikely to meet its existing forecasts. Reuters reported that the stock was down about 2.3% in morning trading, while other market reports recorded larger declines during the session.
Analysts have expressed concerns about the company’s near-term visibility, particularly because the disruption makes it more difficult to determine how much revenue can be recovered through delayed shipments.
The company is expected to provide an updated financial outlook when it reports its third-quarter results on October 28.
Healthcare Remains a High-Value Cyber Target
The incident also highlights the particular risks facing healthcare and medical-technology companies.
Medical-device manufacturers operate complex networks connecting factories, logistics systems, corporate infrastructure and, in some cases, connected healthcare products. A successful intrusion can therefore create consequences that extend beyond stolen information.
Boston Scientific said the incident did not compromise product quality, although there was some disruption involving activation of its cardiac remote-monitoring devices.
That distinction is important because cyberattacks against healthcare companies can potentially affect both business continuity and services connected to patients.
Boston Scientific is also not alone. Recent cybersecurity incidents have affected other major healthcare companies, including Abbott, Stryker and Medtronic, illustrating the sector’s growing exposure to cyber threats.
The Financial Cost of Downtime
The Boston Scientific case demonstrates why cybersecurity has increasingly become a board-level financial issue.
An attack does not need to result in a major data breach to create significant losses. Interrupting production, stopping order processing or delaying shipments can generate direct revenue losses while simultaneously increasing recovery costs.
For manufacturers operating complex global supply chains, even a temporary outage can create a backlog that takes weeks to unwind.
Boston Scientific says it is continuing to restore operations and reduce that backlog. The company has not yet provided a complete estimate of the incident’s financial cost.
That uncertainty could remain one of the biggest concerns for investors until the company releases its revised outlook next month.
This website uses cookies.